Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00690976 · ClinicalTrials.gov registry record · NA

Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)

A NA study of HIV Infections, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT00690976: Completed NA study of HIV Infections, sponsored by Centers for Disease Control and Prevention.

NCT00690976 is a NA study of HIV Infections that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 220 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00690976, a NA study of HIV Infections, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to determine the acceptability, feasibility, and the preliminary efficacy of an HIV prevention behavioral intervention (Proyecto SOL) to reduce behaviors associated with HIV acquisition among Hispanic men who have sex with men (HMSM). The primary goal of the intervention is to motivate and assist participants in forming and carrying out a "Safer Options for Life" plan, thereby reducing their risk of HIV acquisition or transmission.

Conditions Studied

Interventions

  • BEHAVIORAL HCT
  • BEHAVIORAL Proyecto SOL

Study Locations (1)

Florida

  • NOVA Southeastern University - Fort Lauderdale

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2008-07
Est. Completion 2010-03
Phase NA

What the finished NCT00690976 record still lists

NCT00690976 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (51% lower).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which HCT is the first listed.

NCT00690976 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT00690976 about?

NCT00690976 is a clinical study titled "Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)". The purpose of this project is to determine the acceptability, feasibility, and the preliminary efficacy of an HIV prevention behavioral intervention (Proyecto SOL) to reduce behaviors associated with HIV acquisition among Hispanic men who have sex with men (HMSM). The primary goal of the interventi...

What is the current status of trial NCT00690976?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2008-07. Estimated completion is 2010-03.

What conditions does trial NCT00690976 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00690976?

The interventions under investigation include: HCT (BEHAVIORAL), Proyecto SOL (BEHAVIORAL).

Who is sponsoring clinical trial NCT00690976?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00690976 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00690976's enrollment target sits among peer trials

220 158th of 542 higher than 383 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00690976, the US trial registry maintained by the National Library of Medicine. NCT00690976 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.